Author:
Klee Bianca,Diexer Sophie,Xu Chao,Gottschick Cornelia,Hartmann Carla,Meyer-Schlinkmann Kristin Maria,Kuhlmann Alexander,Rosendahl Jonas,Binder Mascha,Gekle Michael,Girndt Matthias,Höll Jessica I.,Moor Irene,Sedding Daniel,Moritz Stefan,Frese Thomas,Mikolajczyk Rafael
Abstract
Abstract
Purpose
We investigated the protection offered by vaccinations and previous infections for the household transmission of Omicron variant of SARS-CoV-2.
Methods
34,666 participants of the German DigiHero cohort study with two or more household members were invited to a prospective household transmission study between June and December 2022. In case of a positive SARS-CoV-2 test in a household, symptom diaries were completed for at least 14 days. Dry blood spots (DBS) were taken from all household members at the beginning and six to eight weeks later. DBS were analyzed for SARS-CoV-2 antibodies.
Results
1191 individuals from 457 households participated. The risk of acquiring a SARS-CoV-2 infection decreased with higher S-titer levels at the time of exposure (from 80% at titer of 0 binding antibody units (BAU)/ml to 20% at titer of 3000 BAU/ml) and increased linearly with the time since vaccination/previous infection (20% for less than one month to 80% at one year). Transmission probability was also reduced when the symptoms of the primary case were mild and if preventive measures were implemented.
Conclusion
Vaccinations/previous infections offer a high protection against infection with the Omicron variant for a few months only, supporting the notion of seasonal circulation of the virus.
Funder
Ministerium für Wissenschaft und Wirtschaft, Land Sachsen-Anhalt
Martin-Luther-Universität Halle-Wittenberg
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. 2/7/2024. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic. Accessed 7 Jun 2024
2. One year since the emergence of COVID-19 virus variant Omicron. 2/8/2024. https://www.who.int/news-room/feature-stories/detail/one-year-since-the-emergence-of-omicron. Accessed 7 Jun 2024.
3. Mohsin M, Mahmud S. Omicron SARS-CoV-2 variant of concern: a review on its transmissibility, immune evasion, reinfection, and severity. Medicine (Baltimore). 2022;101: e29165. https://doi.org/10.1097/MD.0000000000029165.
4. Madewell ZJ, Yang Y, Longini IM, Halloran ME, Dean NE. Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis. JAMA Netw Open. 2022;5: e229317. https://doi.org/10.1001/jamanetworkopen.2022.9317.
5. Lyngse FP, Kirkeby CT, Denwood M, Christiansen LE, Mølbak K, Møller CH, et al. Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark. Nat Commun. 2022;13:5760. https://doi.org/10.1038/s41467-022-33498-0.